Literature DB >> 1985031

Helicobacter pylori infection in pernicious anemia: a prospective controlled study.

T L Fong1, C P Dooley, M Dehesa, H Cohen, R Carmel, P L Fitzgibbons, G I Perez-Perez, M J Blaser.   

Abstract

Although some authors believe that Helicobacter pylori is the etiologic agent in chronic nonspecific gastritis, it has also been suggested that the bacterium colonizes inflamed mucosa as a secondary event. This study documents the prevalence of H. pylori in 28 patients with pernicious anemia and compares the findings with those of a group of 28 age-, race-, and sex-matched asymptomatic control subjects. All subjects underwent endoscopy with biopsy of the gastric antrum and corpus. A sample of serum was obtained before endoscopy for determination of antibodies (immunoglobulin A and immunoglobulin G) to H. pylori. The prevalence of H. pylori (by biopsy) in patients with pernicious anemia was significantly less than that in controls (11% vs. 71%, P less than 0.0001). All patients with pernicious anemia had abnormalities of corpus histology (inflammation and/or atrophy). In addition, 50% of patients with pernicious anemia had a lymphocytic infiltration of the antrum. All controls with H. pylori had gastritis, 50% having active chronic gastritis. Atrophic changes of the corpus were more commonly found in patients with pernicious anemia (75% vs. 7%, P less than 0.0001). Serology and biopsy results correlated poorly in the patients with pernicious anemia: all 5 patients with positive serology results had negative biopsy results, whereas all 3 patients with positive cultures on biopsy had negative serological studies. In conclusion, patients with pernicious anemia are protected from infection with H. pylori, and H. pylori does not passively colonize mucosa inflamed by an unrelated process.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1985031     DOI: 10.1016/0016-5085(91)90199-u

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  28 in total

1.  Autoimmune gastritis: is Helicobacter pylori a merely commensal or a pathogenic agent?

Authors:  G Cariani; A Vandelli; G Fontana; G Bonora; G Mazzoleni
Journal:  Dig Dis Sci       Date:  1992-08       Impact factor: 3.199

Review 2.  Helicobacter pylori and peptic ulcers: the present position.

Authors:  S Moss; J Calam
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

3.  Vitamin B12 deficiency and gastric histopathology in older patients.

Authors:  K-R Dholakia; T-S Dharmarajan; D Yadav; S Oiseth; E-P Norkus; C-S Pitchumoni
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

4.  Gastric carcinoid tumors without autoimmune gastritis in Japan: a relationship with Helicobacter pylori infection.

Authors:  Yuichi Sato; Mitsuya Iwafuchi; Jun-Ichi Ueki; Akira Yoshimura; Tsutomu Mochizuki; Hirotaka Motoyama; Kazuhito Sugimura; Terasu Honma; Rintaro Narisawa; Takafumi Ichida; Hitoshi Asakura; D H Van Thiel
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

Review 5.  Optimizing acid suppression for treatment of acid-related diseases.

Authors:  R H Hunt; C Cederberg; J Dent; F Halter; C Howden; I N Marks; S Rune; R P Walt
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

6.  H. pylori infection in HIV-positive patients. A serohistological study.

Authors:  P Fabris; L Bozzola; P Benedetti; M Scagnelli; R Nicolin; V Manfrin; C Scarparo; F De Lalla
Journal:  Dig Dis Sci       Date:  1997-02       Impact factor: 3.199

7.  Histological study of chronic gastritis from the United Arab Emirates using the Sydney system of classification.

Authors:  A M Zaitoun
Journal:  J Clin Pathol       Date:  1994-09       Impact factor: 3.411

8.  Inhibitory effects of Helicobacter pylori infection on murine autoimmune gastritis.

Authors:  M Ohana; K Okazaki; C Oshima; K Kawasaki; T Fukui; H Tamaki; M Matsuura; M Asada; T Nishi; K Uchida; S Uose; H Nakase; M Iwano; Y Matsushima; H Hiai; T Chiba
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

9.  Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective, randomized, and controlled study.

Authors:  J Labenz; E Gyenes; G H Rühl; G Börsch
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

10.  Helicobacter pylori, gastritis, and peptic ulceration in the elderly.

Authors:  J I Wyatt; T M Shallcross; J E Crabtree; R V Heatley
Journal:  J Clin Pathol       Date:  1992-12       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.